Bulgaria is set to adopt the euro on 1 January 2026, marking a major shift in its monetary regime and one that carries important implications for pharmaceutical pricing and market dynamics. Although the domestic legislative transition appears relatively straightforward — with automatic conversion rules for local...
💶 Here’s what Marketing Authorisation Holders (MAHs) need to know about medicine prices Bulgaria is officially switching to the euro on 1 January 2026. As part of this change, the prices of all medicinal products will be aligned with the new currency, in accordance with the...
After the amendments to the Bulgarian regulation on pricing and reimbursement in December 2014, it became increasingly difficult to determine whether the government is regulating or merely registering OTC prices in Bulgaria. Under the Bulgarian Law on Medicinal Products in Human Medicine (the Drug Law), the...
The prices of RX medicinal products are regulated by the National Council on Pricing and Reimbursement in Bulgaria. Before placing any RX medicinal product (whether reimbursed or non-reimbursed) on the Bulgarian market the concerned marketing authorisation holders (MAH) have to initiate administrative procedure for price...